ENOV Enovis Corporation

NYSE
$18.46

Enovis Corporation (ENOV) is expected to report earnings on November 6, 2026, before the market open. The consensus earnings estimate is $0.64 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -36.0% since its last earnings release on August 6, 2026.

Enovis Missed Consensus Estimates, Reaffirms
Thursday, August 6, 2026 · 6:05 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 6
Friday · 6:05 AM ET
Earnings Whisper
-
vs $0.64
Rev est $555.63M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $21.03

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Enovis Corporation

Enovis Corporation is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 4 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.